These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 19748321

  • 1. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J.
    Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
    [Abstract] [Full Text] [Related]

  • 2. Natural antibodies against phosphorylcholine in cardiovascular disease.
    de Faire U, Frostegård J.
    Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

  • 4. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
    de Faire U, Su J, Hua X, Frostegård A, Halldin M, Hellenius ML, Wikström M, Dahlbom I, Grönlund H, Frostegård J.
    J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160
    [Abstract] [Full Text] [Related]

  • 5. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
    Freire de Carvalho J, Sherer Y, Shoenfeld Y.
    Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
    [Abstract] [Full Text] [Related]

  • 6. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX.
    Arch Immunol Ther Exp (Warsz); 2004 Dec; 52(4):225-39. PubMed ID: 15467487
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H, Hallmans G, Jansson JH, Boman K, Wikström M, de Faire U, Frostegård J.
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J, Witztum JL, Xu Q.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2436-43. PubMed ID: 16781371
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ, van Halm VP, Nurmohamed MT, Damoiseaux J, Tervaert JW, Twisk JW, Dijkmans BA, Voskuyl AE.
    J Rheumatol; 2008 Aug 20; 35(8):1495-9. PubMed ID: 18597411
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G, Seven A, Uncu M, Cantaşdemir M, Numan F, Burçak G.
    Scand J Clin Lab Invest; 2008 Aug 20; 68(6):473-8. PubMed ID: 18609113
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J.
    Clin Chim Acta; 2004 Oct 20; 348(1-2):1-8. PubMed ID: 15369729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun 20; 1051():442-54. PubMed ID: 16126986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.